Covid-19: Centre to buy one crore doses of Zydus Cadila's vaccine at Rs 265 each

By Jasleen Kaur -- November 08, 2021 6:49 pm -- Updated:November 08, 2021 6:54 pm

Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first Plasmid DNA Covid-19 vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding GST, said the company on Monday.

According to a statement issued by Zydus Cadila, the pricing has been decided in consultation with the Government of India.

Zydus Cadila to reduce its 'needle-free' Covid vaccine price to Rs 265/dose: Sources | India News – India TV

Speaking on the development, the company MD, Dr Sharvil Patel, said, "We are happy to support the Government of India's vaccination programme with ZyCoV-D. The needle-free application of the vaccination, we hope, will motivate many more to vaccinate and safeguard themselves from Covid-19, especially children and young adults in the age group of 12 to 18 years."

Also read | Women’s hockey team captain Rani Rampal conferred with Padma Shri

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus. It is also the first Covid-19 vaccine that is needle-free and administered using PharmaJet, a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.

Zydus Cadila: 265 रुपये में मिलेगी जाइडस कैडिला के कोरोना टीके की एक खुराक! सरकार से बनी सहमति, अंतिम निर्णय जल्द - Zydus cadila agrees to price covid vaccines at rs per

ZyCoV-D has shown good stability at temperatures of around 25 degrees for at least three months. The thermostability of the vaccine will help in easy transportation and storage of the vaccine without any problems of fluctuations in temperature.

Also read | LeT terrorist arrested in Jammu and Kashmir’s Anantnag, arms recovered

For prolonged use, a temperature of 2-8 degrees is sufficient. Also being a DNA plasmid vaccine, ZyCoV-D doesn't have any problem associated with vector-based immunity. The DNA Plasmid platform allows generating new constructs quickly to deal with mutations in the virus.

Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: Reports | India News,The Indian Express

-PTC News

  • Share